News

COPAN announces its North American launch
of the new Collaborative Robot, its latest addition to Full Laboratory Automation.

Recent multicenter study by Dr. Carey-Ann D. Burnham et al adds another application to the growing number of uses and endorsements for COPAN’s widely popular ESwab™. ESwab™ comprises of 1ml of liquid Amies and a flocked swab that completely elutes the sample into the preservation medium.

Livermore, Calif. – October 20, 2017 – Not-for-profit Sutter Health and COPAN Diagnostics, Inc. (Murrieta, Calif.) today announced the deployment of full automation technology at the Sutter Health Shared Laboratory in Livermore. WASPLab^® will improve patient care by speeding up the diagnosis process, leading to decreases in both cost and length of hospital stays.

The new WASPLab^® at University Health Network/Sinai Health System’s Department of Microbiology in Toronto, Ontario marks the 60th worldwide placement of the innovative instrument.

After a successful launch at the American Society for Microbiology (ASM) Microbe 2017, COPAN is showcasing PhenoMATRIX™ to a wider audience at the American Association for Clinical Chemistry (AACC) annual meeting at the San Diego Convention Center from August 1 through August 3.

COPAN Diagnostics, Inc. will unveil “MilkyWay,” the first fully automated instrument for preparing pour plate total viable bacterial counts on liquid samples, at the International Association for Food Protection Annual Conference in Tampa, Florida today. The conference runs from July 9, 2017 through July 11, 2017. The “MilkyWay” instrument draws from COPAN’s extensive experience in automation and culture of innovation.

In this study, Rebbapragada et al examined FecalSwab’s compatibility with the Seegene’s molecular chemistry, and FecalSwab’s convenience and utility when used with an automated pipetting platform employed within the assay. The study showed FecalSwab’s improved limit of detection when compared to traditional enteric transport media.

A recent study set out to determine the most effective, rapid and least invasive method to collect stool samples and quickly treat patients suffering from gastrointestinal diseases.

Visit COPAN during the Molecular Med Tri-Conference in San Francisco, to discover more about Copan’s B2B molecular transport development capabilities and resources. The booth will feature eNat™, Copan’s successful DNA and RNA preservation system suitable for a variety of sample types including urine and respiratory disease diagnostics or Hospital Acquired Infections (HAI) surveillance testing